BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35558515)

  • 1. The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases.
    Solozhentseva K; Batalov A; Zakharova N; Goryaynov S; Pogosbekyan E; Pronin I
    Front Oncol; 2022; 12():874924. PubMed ID: 35558515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D pseudo-continuous arterial spin labeling-MRI (3D PCASL-MRI) in the differential diagnosis between glioblastomas and primary central nervous system lymphomas.
    Batalov AI; Afandiev RM; Zakharova NE; Pogosbekyan EL; Shulgina AA; Kobyakov GL; Potapov AA; Pronin IN
    Neuroradiology; 2022 Aug; 64(8):1539-1545. PubMed ID: 35112216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial Spin Labeling Perfusion in Determining the IDH1 Status and Ki-67 Index in Brain Gliomas.
    Batalov AI; Zakharova NE; Chekhonin IV; Pogosbekyan EL; Sudarikova AV; Goryainov SA; Shulgina AA; Belyaev AY; Usachev DY; Pronin IN
    Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D pCASL-perfusion in preoperative assessment of brain gliomas in large cohort of patients.
    Batalov AI; Zakharova NE; Pronin IN; Belyaev AY; Pogosbekyan EL; Goryaynov SA; Bykanov AE; Tyurina AN; Shevchenko AM; Solozhentseva KD; Nikitin PV; Potapov AA
    Sci Rep; 2022 Feb; 12(1):2121. PubMed ID: 35136119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas.
    Yoo RE; Choi SH; Cho HR; Kim TM; Lee SH; Park CK; Park SH; Kim IH; Yun TJ; Kim JH; Sohn CH; Han MH; Chang KH
    J Magn Reson Imaging; 2013 Oct; 38(4):852-60. PubMed ID: 23390061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
    Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
    J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of extra-axial brain tumor response to radiotherapy using pseudo-continuous arterial spin labeling images: preliminary results.
    Yamamoto T; Kinoshita K; Kosaka N; Sato Y; Shioura H; Takeuchi H; Kimura H
    Magn Reson Imaging; 2013 Oct; 31(8):1271-7. PubMed ID: 23810102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-contrast ASL perfusion in preoperative diagnosis of supratentorial gliomas].
    Batalov AI; Zakharova NE; Pogosbekyan EL; Fadeeva LM; Goryaynov SA; Baev AA; Shul'ts EI; Chelushkin DM; Potapov AA; Pronin IN
    Zh Vopr Neirokhir Im N N Burdenko; 2018; 82(6):15-22. PubMed ID: 30721213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling.
    Geerts B; Leclercq D; Tezenas du Montcel S; Law-Ye B; Gerber S; Bernardeschi D; Galanaud D; Dormont D; Pyatigorskaya N
    Clin Neuroradiol; 2019 Mar; 29(1):75-86. PubMed ID: 28894884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
    Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
    J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
    Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
    Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of brain perfusion in newborns: pulsed arterial spin labeling (PASL) versus pseudo-continuous arterial spin labeling (pCASL).
    Boudes E; Gilbert G; Leppert IR; Tan X; Pike GB; Saint-Martin C; Wintermark P
    Neuroimage Clin; 2014; 6():126-33. PubMed ID: 25379424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.
    Lin L; Xue Y; Duan Q; Sun B; Lin H; Huang X; Chen X
    Oncotarget; 2016 Oct; 7(42):69051-69059. PubMed ID: 27655705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a 3D pseudocontinuous arterial spin-labeled perfusion MRI scan combined with a postlabeling delay value in the diagnosis of neonatal hypoxic-ischemic encephalopathy.
    Tang S; Liu X; He L; Liu B; Qin B; Feng C
    PLoS One; 2019; 14(7):e0219284. PubMed ID: 31283776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
    Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
    Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive Diagnosis and Prognosis Values of 3D Pseudocontinuous Arterial Spin Labeling and Optical Coherence Tomography Angiography in Proliferative Diabetic Retinopathy.
    Hou Y; Song S; Sun J; Wang H; Wang Y; Wang Z; Li J; Li H
    Front Med (Lausanne); 2021; 8():682708. PubMed ID: 34150814
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of pseudo-continuous arterial spin labeling for renal perfusion imaging.
    Echeverria-Chasco R; Vidorreta M; Aramendía-Vidaurreta V; Cano D; Escalada J; Garcia-Fernandez N; Bastarrika G; Fernández-Seara MA
    Magn Reson Med; 2021 Mar; 85(3):1507-1521. PubMed ID: 33017483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can 3D pseudo-continuous arterial spin labeling perfusion imaging be applied to predict early response to chemoradiotherapy in patients with advanced nasopharyngeal carcinoma?
    Sun Z; Hu S; Xue Q; Jin L; Huang J; Dou W
    Radiother Oncol; 2021 Jul; 160():97-106. PubMed ID: 33951492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography.
    Kilroy E; Apostolova L; Liu C; Yan L; Ringman J; Wang DJ
    J Magn Reson Imaging; 2014 Apr; 39(4):931-9. PubMed ID: 24038544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.